UroGen Pharma Reveals Promising Developments in Latest 8-K Filing
UroGen Pharma Ltd., a pioneering pharmaceutical company with a focus on innovative treatments for urothelial cancers, recently submitted an 8-K form to the Securities and Exchange Commission, highlighting significant events as of January 14, 2025. The filing details the submission of a presentation by UroGen Pharma, which may be utilized in engagements with investors and […]
More Stories
The Good News of Economic Growth
By Jeffrey A. Tucker The Trump administration received some very welcome news in the form of third-quarter economic growth. Even...
Taiwan Gets Dec. 25 Off for First Time in Over 2 Decades
By Lily Zhou Residents of Taiwan got Dec. 25 off for the first time in nearly 25 years after lawmakers...
5 Million Christmas Lights Illuminate 19th Century Ohio Grist Mill
By Jeff Louderback CLIFTON, Ohio—With one flip of a switch, 5 million lights transform one of the country’s largest remaining...
Pentagon Partners With xAI Service for Military’s Growing Artificial Intelligence Toolset
By Ryan Morgan The U.S. military is set to expand its artificial intelligence (AI) toolset in a new partnership with...
DOGE Says 14 Contracts Worth $190 Million Canceled
By Tom Ozimek The Department of Government Efficiency (DOGE) said federal agencies terminated or scaled back 14 additional contracts over...
Transportation Department to Spend Nearly $1 Billion Toward Road Safety
By Naveen Athrappully Transportation Secretary Sean P. Duffy has announced almost $1 billion in funding to “make roads safer for...